PHARMASGP HOLDING SEPHARMASGP HOLDING SEPHARMASGP HOLDING SE

PHARMASGP HOLDING SE

No trades
See on Supercharts

PSG fundamentals

PHARMASGP HOLDING SE financial statements, including revenue, expenses, profit, and loss

The total revenue of PSG for the last quarter is 28.16 M EUR, and it's 6.76% lower compared to the previous quarter. The net income of Q2 24 is 4.12 M EUR.

Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth